NASDAQ:WCRX - Warner Chilcott Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Warner Chilcott (NASDAQ:WCRX)

Warner Chilcott logoWarner Chilcott Public Limited Company is a specialty pharmaceutical company. The Company is focused on the women's healthcare, gastroenterology, dermatology and urology segments of the branded pharmaceuticals market, primarily in North America. The Company's hormonal contraceptive product offerings include LOESTRIN 24 FE (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), the branded product in the United States hormonal contraception market, and LO LOESTRIN FE (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets), its new oral contraceptive product, launched in January 2011, that offers women the lowest dosage of estrogen of any oral contraceptive available in the United States market. In October 2013, Actavis Inc acquired the entire share capital of Warner Chilcott PLC.

Receive WCRX News and Ratings via Email

Sign-up to receive the latest news and ratings for WCRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
SymbolNASDAQ:WCRX
CUSIPG9436810
WebN/A
Phone+353-1-8972000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Warner Chilcott (NASDAQ:WCRX) Frequently Asked Questions

What is Warner Chilcott's stock symbol?

Warner Chilcott trades on the NASDAQ under the ticker symbol "WCRX."

Has Warner Chilcott been receiving favorable news coverage?

Media headlines about WCRX stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Warner Chilcott earned a coverage optimism score of 0.15 on Accern's scale. They also assigned news articles about the specialty pharmaceutical company an impact score of 46.31 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

How do I buy shares of Warner Chilcott?

Shares of WCRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Warner Chilcott?

Warner Chilcott's mailing address is Grand Canal Square, DUBLIN,, Ireland. The specialty pharmaceutical company can be reached via phone at +353-1-8972000.


MarketBeat Community Rating for Warner Chilcott (WCRX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  148 (Vote Outperform)
Underperform Votes:  122 (Vote Underperform)
Total Votes:  270
MarketBeat's community ratings are surveys of what our community members think about Warner Chilcott and other stocks. Vote "Outperform" if you believe WCRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WCRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.